This sponsored supplement was produced by Focus Reports.
Project Director: Mary Carmen Luna
Project and Editorial Coordinator: Aleksandra Klassen
Project Publisher: Ines Nandin
Editor: Fred Gebhart
For exclusive interviews and more info, please log onto http://Pharma.FocusReports.net/ or write to contact@focusreports.net
"Status" by Jane Lee
|
Thousands have followed Tom Waits' "we sail tonight for Singapore" beckoning call.
Today, Singapore is the second most densely populated country on the planet (after only Monaco,) with a population of over
five million in 435 square miles.
Ranging from the quaint—Prime Minister Lee Hsien Loong urging Singaporeans to procreate—to the ascetic—a hard-line legal system
where capital punishment is allowed—the government blankets the city-state. Occasionally, it is difficult to decipher whether
its denizens are living in a contemporary "1984," which has managed to convince the rest of the world of its superiority,
or whether an administration can really be so cohesive and so responsive that the public's universal woes are eradicated.
Keat Chuan Yeo, Executive Director Singapore Economic Development Board
|
So call it an Orwellian-esque tale, "Asia-light", as it is called by excited greenhorns and haughty expats alike, or the Silicon
Valley of the East. In under 50 years, Singapore has managed to develop a knowledge-based economy. For the seventh consecutive
year it has been awarded the best business environment by the World Bank and currently ranks as the 4th highest GDP per capita.
Most executives across the pharmaceutical industry agree—Singapore does not represent any question marks in the future. Furthermore,
Singapore's location is ideal for reaching markets east, west, north and south, which form the powerhouse that is Asia Pacific.
PharmExec Blog
Follow Us
RSS
Bookstore
